BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2410998)

  • 1. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 2. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the beta-TG/PF4 ratio have any value?
    Arocha-Piñango CL; Ojeda A
    Thromb Haemost; 1983 Apr; 49(2):147. PubMed ID: 6191402
    [No Abstract]   [Full Text] [Related]  

  • 6. Standardization of beta-thromboglobulin and platelet factor 4: a collaborative study to investigate the sources and extent of variation in the measurement of platelet specific proteins.
    Curtis AD; Kerry PJ
    Thromb Haemost; 1983 Oct; 50(3):686-9. PubMed ID: 6196853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of various parameters of platelet function in subjects with type II diabetes mellitus. Methodologic study of the changes in PF4 and beta-TG].
    Ferri GM; Afeltra A; Caccavo D; Amoroso A
    Recenti Prog Med; 1986 Jan; 77(1):31-2. PubMed ID: 2422709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta-thromboglobulin (author's transl)].
    Endo Y
    Rinsho Byori; 1981 Jan; 29(1):20-5. PubMed ID: 6169853
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P; Cortelazzo S; Bassan R; Barbui T
    Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
    Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
    Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
    [No Abstract]   [Full Text] [Related]  

  • 12. PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders.
    Luzzatto G; Fabris F; Mazzucato M; Girolami A
    Scand J Haematol; 1985 Sep; 35(3):299-304. PubMed ID: 2414843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PF,VIII/vWF,B-TG and PF4 in diabetic subjects, both type 1 and 2, with and without retinopathy.
    Guastamacchia E; Di Paolo S; Santoro G; Damato A; Nardelli GM; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):499-505. PubMed ID: 2412573
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical applications of beta-thromboglobulin and platelet factor 4 radioimmune assays (author's transl)].
    Lokiec F; Najean Y
    Nouv Presse Med; 1980 Oct; 9(38):2833-4, 2837-8. PubMed ID: 6160454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
    Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
    Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of platelet-specific protein, beta-thromboglobulin, and its significance].
    Sakuragawa N
    Rinsho Byori; 1979; Suppl 40():138-42. PubMed ID: 95204
    [No Abstract]   [Full Text] [Related]  

  • 17. beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in obstetrical cases.
    Arocha-Piñango CL; Ojeda A; López G; García L; Linares J
    Acta Obstet Gynecol Scand; 1985; 64(2):115-20. PubMed ID: 2580418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma levels of beta-thromboglobulin and platelet factor 4 in migraine accompagnée].
    Scharf RE; Schneider W; Hennericic M
    Dtsch Med Wochenschr; 1983 Jul; 108(30):1169-70. PubMed ID: 6197270
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma and platelet beta-thromboglobulin in chronic myeloproliferative disorders.
    Endo Y; Mamiya S; Satoh M
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):118-23. PubMed ID: 6171982
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of anticoagulant mixtures on BTG and PF4 levels.
    Randi ML; Fabris F; Casonato A; Girolami A
    Thromb Haemost; 1981 Aug; 46(2):569. PubMed ID: 6171043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.